Zantac, a heartburn drug, should be immediately removed from the market, the Food and Drug Administration (FDA) said on Wednesday. Manufactures should withdraw all versions of the drug because the agency has determined an impurity, N-nitrosodimethylamine (NDMA), in some of them increases over time, potentially resulting in unacceptable levels of the impurity. “We didn’t observe […]